Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®
INTERPACE BIOSCIENCES INC (IDXG)
Last interpace biosciences inc earnings: 11/13 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
interpacediagnostics.com/investors
Company Research
Source: GlobeNewswire
New Article in Peer-Reviewed Journal Highlights Important Role of PancraGEN?® Testing PARSIPPANY, NJ, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today a new scientific paper was published and the primary conclusion showed that DNA analysis using PancraGEN® has a favorable impact on patient outcomes particularly in patients with cysts that have worrisome features supporting more accurate surgery and surveillance decisions. The paper entitled “The Incremental Value of DNA Analysis in Pancreatic Cysts Stratified by Clinical Risk Factors” was published in the November edition of Gastrointestinal Endoscopy, the official peer-reviewed publication of the American Society for Gastrointestinal Endoscopy. The three DNA abnormalities examined in the study, all of which are included in the PancraGEN® assay, included: elevated DNA quantity, KRAS mutation, and loss of heterozygosity (LOH) mutations among a panel of key tumor suppressor gen
Show less
Read more
Impact Snapshot
Event Time:
IDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDXG alerts
High impacting INTERPACE BIOSCIENCES INC news events
Weekly update
A roundup of the hottest topics
IDXG
News
- Interpace Biosciences Announces First Quarter 2024 Financial and Business Results [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces First Quarter 2024 Financial and Business ResultsGlobeNewswire
- Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business ResultsGlobeNewswire
IDXG
Sec Filings
- 5/9/24 - Form 8-K
- 5/9/24 - Form 10-Q
- 4/26/24 - Form 10-K/A
- IDXG's page on the SEC website